Progressive intermittent claudication is associated with impaired fibrinolysis

Journal of Vascular Surgery

Volumn 27, Issue 4, 1998, Pages 645-650

  Killewich, L A ^a   Gardner, A W ^a   Macko, R P ^a   Hanna, D J ^a   Goldberg, A P ^a   Cox, D K ^a   Flinn, W R ^a  

^a UNIVERSITY OF MARYLAND MEDICAL SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR;

AGED; ARTERY DISEASE; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBRINOLYSIS; HUMAN; INTERMITTENT CLAUDICATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

EID: 0031916918     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0741-5214(98)70229-0     Document Type: Article

References (32)

1. A Hamsten B Wiman U DeFaire M. Blomback Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction N Engl J Med 313 1985 1557 1563
2. J Aznar A Estelles G Tormo P Sapena V Tormo S Blanch Plasminogen activator inhibitor activity and other fibrinolytic variables in patients with coronary artery disease Br Heart J 59 1988 535 541
3. A Lindgren C Lindoff B Norrving B Astedt BB. Johansson Tissue plasminogen activator and plasminogen activator inhibitor-1 in stroke patients Stroke 27 1996 1066 1071
4. M Cortellaro C Boschetti E Cofrancesco C Zanussi M Catalano G de Gaetano The PLAT study: hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients: principal results Arterioscler Thromb 12 1992 1063 1070
5. WB Kannel PA Wolf WP Castelli RB D'Agostino Fibrinogen and risk of cardiovascular disease: the Framingham study JAMA 258 1987 1183 1186
6. M Benderly E Graff H Reicher-Reiss S Behar D Brunner U Goldbourt Fibrinogen is a predictor of mortality in coronary heart disease patients Arterioscler Thromb Vasc Biol 16 1996 351 356
7. K Huber M Jorg P Probst E Schuster I Lang G Kaindl A decrease in plasminogen activator inhibitor 1 activity is associated with a significantly reduced risk for coronary restenosis Thromb Haemost 67 1992 209 213
8. JH Jansson TK Nilsson BO. Olofsson Tissue plasminogen activator and other risk factors as predictors of cardiovascular events in patients with severe angina pectoris Eur Heart J 12 1991 157 161
9. C Held P Hjemdahl N Rehnqvist NH Wallen I Bjorkander SV Eriksson Fibrinolytic variables and cardiovascular prognosis in patients with stable angina pectoris treated with verapamil or metoprolol Circulation 95 1997 2380 2386
10. GDO Lowe FGR Fowkes J Dawes PT Donnan SE Lennie E. Housley Blood viscosity, fibrinogen, and activation of coagulation and leukocytes in peripheral arterial disease and the normal population in the Edinburgh artery study Circulation 87 1993 1915 1920
11. K Handa M Takao J Nomoto K Oku K Shirai K Saku Evaluation of the coagulation and fibrinolytic systems in men with intermittent claudication Angiology 47 1996 543 548
12. M Cortellaro E Cofrancesco C Boschetti L Mussoni MB Donati M Catalano Association of increased fibrin turnover and defective fibrinolytic capacity with leg atherosclerosis Thromb Haemost 72 1994 292 296
13. M De Buyzere J Philippe D Duprez G Baele DL. Clement Coagulation system activation and increase of D-dimer levels in peripheral arterial occlusive disease Am J Hematol 43 1993 91 94
14. M Cortellaro E Cofrancesco C Boschetti L Mussoni MB Donati M Cardillo Increased fibrin turnover and high PAI-1 activity as predictors of ischemic events in atherosclerotic patients: a case-control study Arterioscler Thromb 13 1993 1412 1417
15. J Johansson N Egberg H Johnsson LA. Carlson Serum lipoproteins and hemostatic function in intermittent claudication Arterioscler Thromb 13 1993 1441 1448
16. PS Montgomery AW. Gardner The clinical utility of a six minute walk test in peripheral arterial occlusive disease patients J Am Geriatr Assoc 1998 [in press]
17. MJ Pentecost MH Criqui G Dorros J Goldstone KW Johnston EC Martin Guidelines for peripheral percutaneous transluminal angioplasty of the abdominal aorta and lower extremity vessels Circulation 89 1994 511 531
18. P Angleton WL Chandler G. Schmer Diurnal variation of tissue-type plasminogen activator and its rapid inhibitor (PAI-1) Circulation 79 1989 101 106
19. WL Chandler G Schmer JR. Stratton Optimal conditions for the stabilization and measurement of tissue plasminogen activator in human plasma J Lab Clin Med 113 1989 362 371
20. JC Files TW Malpass EK Yee JL Ritchie LA. Harker Studies of human platelet alpha-granule release in vivo Blood 58 1981 607 618
21. WL Chandler SC Loo SV Nguyen G Schmer JR. Stratton Standardization of methods for measuring plasminogen activator inhibitor activity in human plasma Clin Chem 35 1989 787 793
22. PJ Gaffney AD. Curtis A collaborative study to establish the 2nd international standard for tissue plasminogen activator (tPA) Thromb Haemost 58 1987 1085 1087
23. WL Chandler RC Veith J. Fellingham Fibrinolytic response during exercise and epinephrine infusion in the same subjects J Am Coll Cardiol 19 1992 1412 1420
24. PM Zack T Ischinger UT Aker B Dincer HL. Kennedy The occurrence of angiographically detected intracoronary thrombus in patients with unstable angina Am Heart J 108 1984 1408 1412
25. MA DeWood J Spores R Notske LT Mouser R Burroughs MS Golden Prevalence of total coronary occlusion in the early hours of transmural myocardial infarction N Engl J Med 303 1980 897 902
26. MJ Davies A. Thomas Thrombosis and acute coronary artery lesions in sudden cardiac ischemic death N Engl J Med 310 1984 1137 1140
27. I Juhan-Vague SDM Pyke MC Alessi J Jespersen F Haverkate SG. Thompson Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris Circulation 94 1996 2057 2063
28. I Juhan-Vague MC. Alessi Plasminogen activator inhibitor 1 and atherothrombosis Thromb Haemost 70 1993 138 143
29. J Gram J. Jespersen A selective depression of tissue plasminogen activator (tPA) activity in euglobulins characterizes a risk group among survivors of acute myocardial infarction Thromb Haemost 57 1987 137 139
30. WL Chandler MC Alessi MF Aillaud P Henderson P Vague I. Juhan-Vague Clearance of tissue plasminogen activator (tPA) and tPA/plasminogen activator inhibitor type 1 (PAI-1) complex: relationship to elevated tPA antigen in patients with high PAI-1 activity levels Circulation 96 1997 761 768
31. JR Stratton WL Chandler RS Schwartz MD Cerquiera WC Levy Effects of physical conditioning on fibrinolytic variables and fibrinogen in young and old healthy adults Circulation 83 1991 1692 1697
32. A Estelles J Aznar G Tormo P Sapena V Tormo F. Espana Influence of a rehabilitation sports programme on the fibrinolytic activity of patients after myocardial infarction Thromb Res 55 1989 203 212